Drug Description in Trials / DrugBank / KEGG DRUG /


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11) Inosine 5'-monophosphate[1] Inosine[1] D00054 --[1] 17
21-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----[1] 17
3[18F]FDOPA----[2] 6, 17
4[F-18]PBR06----[2] 13, 17
5AAV2-GDNF gene therapy----[1] 17
6Abdominal compression----[2] 6, 17
7Accelerometer----[1] 17
8Adjuvant without active component----[2] 6, 17
9AFFITOPE® PD01A + Adjuvant----[2] 6, 17
10AFFITOPE® PD03A + Adjuvant----[1] 17
11Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation----[1] 17
12Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation----[1] 17
13Ampreloxetine[1] Ampreloxetine[1] D11688 [2] SLC6A2,
SLC6A4 💬
[2] Serotonergic synapse, Synaptic vesicle cycle 💬[2] 6, 17
14Ampreloxetine chydrochloride[1] Ampreloxetine[1] D11688 [2] SLC6A2,
SLC6A4 💬
[2] Serotonergic synapse, Synaptic vesicle cycle 💬[2] 6, 17
15Ampreloxetine hydrochloride[1] Ampreloxetine[1] D11688 [2] SLC6A2,
SLC6A4 💬
[2] Serotonergic synapse, Synaptic vesicle cycle 💬[2] 6, 17
16Angiotensin[1] Angiotensin II[2] D00150 ,
D02014
[2] AGTR1,
AGTR2 💬
[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[7] 17, 19, 46, 66, 86, 222, 224
17Angiotensin-(1-7)[1] Angiotensin II[2] D00150 ,
D02014
[2] AGTR1,
AGTR2 💬
[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 17
18Anti-Parkinson medication----[5] 5, 6, 7, 8, 17
19ATH434 dose level 1----[1] 17
20ATH434 dose level 2----[1] 17
21Atomexetine----[1] 17
22Atomoxetine[1] Atomoxetine[2] D02574 ,
D07473
[1] SLC6A2 💬[1] Synaptic vesicle cycle 💬[4] 6, 8, 13, 17
23Autologous Adipose Mesenchymal Stem Cell Implantation----[1] 17
24Autologous mesenchymal stem cells----[5] 2, 6, 13, 17, 46
25Automated abdominal binder----[1] 17
26AZD3241----[2] 6, 17
27AZD3241 100mg----[1] 17
28AZD3241 300mg----[1] 17
29Azilect[1] Rasagiline[3] D02562 ,
D08469 ,
D10829
[1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[4] 2, 5, 6, 17
30AZILECT 1 mg comprimidos[1] Rasagiline[3] D02562 ,
D08469 ,
D10829
[1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
31Behavioral: BCI-FIT active querying----[3] 2, 6, 17
32Behavioral: BCI-FIT adaptive signal modeling----[3] 2, 6, 17
33Behavioral: BCI-FIT language modeling----[3] 2, 6, 17
34Behavioral: BCI-FIT multi-modal access----[3] 2, 6, 17
35Behavioral: Clinical characteristics of AMS patients----[1] 17
36Behavioral: Conservative Measures for Orthostatic Hypotension----[2] 6, 17
37Behavioral: MOntreal Cognitive Assessment (MoCA)----[1] 17
38BHV-3241----[1] 17
39BHV-4157----[1] 17
40BIIB101----[1] 17
41Blood sampling----[6] 13, 17, 19, 46, 51, 96
42BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
43BQ123----[1] 17
44Brain Magnetic Resonance Imaging (MRI)----[1] 17
45BYDUREON[1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 6, 17
46Captopril[1] Captopril[1] D00251 [1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[2] 17, 86
47Carbidopa[1] Carbidopa[1] D00558 [1] DDC 💬[9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[9] 2, 4, 6, 13, 17, 90, 140, 164, 201
48Carbidopa 200mg oral dose[1] Carbidopa[1] D00558 [1] DDC 💬[9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
49Carbonate[1] Carbonate ion---[12] 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
50CS10BR05----[1] 17
51DaTSCAN[1] Ioflupane I-123---[4] 2, 5, 6, 17
52DaTSCAN™ Ioflupane (123I) Injection[1] Ioflupane I-123---[3] 5, 6, 17
53Deep Brain Stimulation----[5] 5, 6, 7, 8, 17
54Determination of objective and subjective pain threshold----[1] 17
55Diagnostic Test: [18F]-RO6958948----[5] 5, 6, 7, 17, 127
56Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau----[5] 5, 6, 7, 17, 127
57Diagnostic Test: Flutemetamol F18 Injection[1] Flutemetamol (18F)---[5] 5, 6, 7, 17, 127
58Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau----[5] 5, 6, 7, 17, 127
59Domperidone[1] Domperidone[2] D01745 ,
D07868
[1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[5] 6, 13, 17, 51, 230
60DOPS[1] Droxidopa[1] D01277 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 17
61Droxidopa[1] Droxidopa[1] D01277 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[5] 5, 6, 17, 169, 170
62EGCG[1] Epigallocatechin gallate---[9] 6, 8, 13, 17, 28, 85, 113, 206, 299
63EGCG as putative neuroprotective agent[1] Epigallocatechin gallate---[1] 17
64Emeramide[1] Emeramide---[2] 5, 17
65ENTACAPONE[1] Entacapone[1] D00781 [1] COMT 💬[4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬[2] 6, 17
66Entacapone 400mg oral dose[1] Entacapone[1] D00781 [1] COMT 💬[4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬[2] 6, 17
67EXENATIDE[1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233
68Exenatide Pen Injector [Bydureon][1] Exenatide[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 17
69Fipamezole[1] Fipamezole---[2] 6, 17
70Fipamezole hydrochloride[1] Fipamezole---[2] 6, 17
71Fipamezole hydrochloride 30 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
72Fipamezole hydrochloride 60 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
73Fipamezole hydrochloride 90 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
74Fludrocortisone[1] Fludrocortisone[2] D00986 ,
D07967
[1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[3] 6, 17, 81
75Flumazenil[1] Flumazenil[1] D00697 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 13, 17, 18, 206
76FLUOXETINE[1] Fluoxetine[2] D00326 ,
D00823
[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 13, 17, 78, 86
77Fluoxétine[1] Fluoxetine[2] D00326 ,
D00823
[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 17
78Flutemetamol[1] Flutemetamol (18F)---[5] 5, 6, 7, 17, 127
79Flutemetamol F18[2] Flutemetamol,
Flutemetamol (18F)
---[5] 5, 6, 7, 17, 127
80Gold[1] Gold---[43] 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318
81Green Tea[1] Green tea leaf[1] D06903 --[5] 6, 17, 28, 46, 96
82GREEN TEA LEAF[2] Green tea leaf,
Tea leaf
[1] D06903 --[1] 17
83Homeostasis Model Assessment of insulin resistance (HOMA)----[1] 17
84Hydrogen[1] Hydrogen---[7] 5, 6, 13, 17, 83, 97, 226
85Inosine[1] Inosine[1] D00054 --[5] 2, 6, 13, 17, 122
86Intranasal Insulin----[2] 6, 17
87Intravenous immunoglobulin (IVIg)[1] Human immunoglobulin G---[4] 14, 17, 164, 296
88Intravesical injection of Botulinum A toxin----[2] 6, 17
89IUPAC name: 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----[1] 17
90IVIG[1] Human immunoglobulin G---[8] 11, 13, 14, 17, 35, 50, 51, 65
91JP-1730/F01----[2] 6, 17
92JP-1730/F02----[2] 6, 17
93JP-1730/F03----[2] 6, 17
94L-Threo DOPS[1] Droxidopa[1] D01277 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
95Levodopa[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[8] 2, 4, 6, 17, 90, 140, 164, 201
96Levodopa test[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 17
97LITHIUM CARBONATE[2] Carbonate ion,
Lithium carbonate
[1] D00801 --[6] 2, 13, 17, 18, 19, 127
98LITIO CARBONATO----[2] 2, 17
99Losartan[1] Losartan[2] D00357 ,
D08146
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
100Lu AF82422----[2] 6, 17
101Metoprolol[1] Metoprolol[3] D00601 ,
D02358 ,
D05011
[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[6] 17, 57, 58, 113, 193, 226
102Metoprolol tartrate 50 mg[1] Metoprolol[3] D00601 ,
D02358 ,
D05011
[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
103Midodrine[1] Midodrine[2] D01307 ,
D08220
[3] ADRA1A,
ADRA1B,
ADRA1D 💬
[7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 6, 17, 58
104Midodrine or atomoxetine pill[2] Atomoxetine,
Midodrine
[4] D01307 ,
D02574 ,
D07473 ,
D08220
[4] ADRA1A,
ADRA1B,
ADRA1D,
SLC6A2 💬
[8] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 17
105Modal----[5] 2, 6, 17, 46, 70
106N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----[2] 5, 17
107NBMI----[2] 5, 17
108Nebivolol[1] Nebivolol[1] D05127 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 17, 85, 113, 167
109Nebivolol 5 mg[1] Nebivolol[1] D05127 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
110Nitrogen[1] Nitrogen[1] D00083 --[6] 5, 6, 17, 171, 211, 299
111Normal Saline----[18] 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299
112NT 101----[4] 5, 6, 7, 17
113Other: Abdominal compression----[1] 17
114Other: Brain MRI (magnetic resonance imaging)----[1] 17
115Other: Sham abdominal compression----[1] 17
116PROZAC----[1] 17
117Pseudoephedrine[1] Pseudoephedrine[4] D00485 ,
D05648 ,
D05649 ,
D08449
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
118Pseudoephedrine + 480 ml water[2] Pseudoephedrine,
Water
[5] D00001 ,
D00485 ,
D05648 ,
D05649 ,
D08449
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
119Pseudoephedrine + 50 ml water[2] Pseudoephedrine,
Water
[5] D00001 ,
D00485 ,
D05648 ,
D05649 ,
D08449
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
120Raclopride[1] Raclopride---[4] 5, 6, 7, 17
121Radiation: H215O PET----[2] 6, 17
122Radiation: PET (Positron Emission Tomography) Study----[1] 17
123Rasagilina[1] Rasagiline[3] D02562 ,
D08469 ,
D10829
[1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
124RASAGILINA MESILATO[1] Rasagiline[3] D02562 ,
D08469 ,
D10829
[1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
125Rasagiline[1] Rasagiline[3] D02562 ,
D08469 ,
D10829
[1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[4] 2, 5, 6, 17
126RASAGILINE MESYLATE[1] Rasagiline[3] D02562 ,
D08469 ,
D10829
[1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
127Rifampicin[1] Rifampicin[1] D00211 --[6] 6, 17, 46, 93, 299, 338
128RILUZOLE[1] Riluzole[1] D00775 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
[23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[9] 2, 3, 5, 8, 13, 17, 18, 203, 206
129Rituximab[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[49] 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
130SAFINAMIDE[1] Safinamide[1] D10158 [1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
131SAFINAMIDE METANSOLFONATO[1] Safinamide[1] D10158 [1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
132SAFINAMIDE METHANESULFONATE[1] Safinamide[1] D10158 [1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
133Saline----[10] 6, 13, 17, 53, 67, 78, 86, 97, 168, 299
134Sham binder----[1] 17
135Sham compression----[2] 6, 17
136Sildenafil25 mg----[1] 17
137Sirolimus[1] Sirolimus[1] D00753 [1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[36] 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331
138Sirolimus 2 MG[1] Sirolimus[1] D00753 [1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 17
139Sunphenon EGCG[1] Epigallocatechin gallate---[3] 13, 17, 113
140TD-9855----[2] 6, 17
141Tea leaf[1] Tea leaf---[1] 17
142Tllsh2910----[1] 17
143Tolterodine[1] Tolterodine[2] D00646 ,
D01148
[1] CHRM3 💬[11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[2] 17, 53
144Trimethaphan[1] Trimethaphan[1] D00612 [1] CHRNA10 💬[1] Neuroactive ligand-receptor interaction 💬[1] 17
145Ubiquinol[1] Ubiquinol---[3] 6, 8, 17
146Verdiperstat[1] Verdiperstat[1] D11684 [1] MPO 💬[5] Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬[3] 2, 17, 127
147Water[1] Water[1] D00001 --[23] 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299
148Xadago[1] Safinamide[1] D10158 [1] MAOB 💬[14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17
149Xeomin[1] Botulinum toxin type A[1] D00783 [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[7] 5, 6, 7, 13, 15, 17, 113
150Z7219----[1] 17
151Zoledronic acid[1] Zoledronic acid[4] D01968 ,
D06378 ,
D06379 ,
D08689
[1] FDPS 💬[4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[12] 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333
152Zoledronic Acid 5Mg/Bag 100Ml Inj[1] Zoledronic acid[4] D01968 ,
D06378 ,
D06379 ,
D08689
[1] FDPS 💬[4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 5, 6, 17